共 50 条
- [3] Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial Neurology and Therapy, 2023, 12 : 2007 - 2019
- [5] Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (08): : 939 - 944
- [6] Sustained response of galcanezumab in migraine prevention: Patient--level data from a post hoc analysis in patients with episodic or chronic migraine HEADACHE, 2023, 63 (10): : 1380 - 1390
- [9] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494